This Article Full Text Full Text (PDF) All Versions of this Article: 109/1/114    most recent 01.CIR.0000105726.89770.35v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tonduangu, D. Articles by Su, J. B. Search for Related Content PubMed PubMed Citation Articles by Tonduangu, D. Articles by Su, J. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Hazardous Substances DB NITROGLYCERIN Related Collections Heart failure - basic studies

(Circulation. 2004;109:114-119.)
© 2004 American Heart Association, Inc.

Basic Science Reports

Chronic Infusion of Bradykinin Delays the Progression of Heart Failure and Preserves Vascular Endothelium-Mediated Vasodilation in Conscious Dogs

Daniel Tonduangu, MD; Luc Hittinger, MD, PhD; Bijan Ghaleh, PhD; Philippe Le Corvoisier, MD; Lucien Sambin; Stéphane Champagne, MD; Thierry Badoual, MD; Fanny Vincent, MS; Alain Berdeaux, MD, PhD; Bertrand Crozatier, MD, PhD; Jin Bo Su, PhD

From INSERM U400, Faculté de Médecine, Assistance Publique Hôpitaux de Paris, and INSERM EMI 00-01, Faculté de Médecine Paris-Sud (B.G., A.B.), France.

Correspondence to Jin Bo SU, PhD, INSERM U400, Faculté de Médecine, 94010 Créteil, France. E-mail jbsu{at}im3.inserm.fr

Received December 3, 2002; de novo received July 9, 2003; accepted August 20, 2003.

Background— This study examined the effects of chronic bradykinin infusion on hemodynamics and myocardial and endothelial functions during the development of heart failure.

Methods and Results— Sixteen instrumented dogs were randomized to receive through the left atria either vehicle or bradykinin (1 µg/min) during ventricular pacing (250 bpm, 5 weeks). Hemodynamic and left ventricular (LV) parameters and the vasodilator responses to intravenous acetylcholine (0.3 to 3 µg/kg) and nitroglycerin (1 to 10 µg/kg) were examined in the control and after 3 and 5 weeks of pacing. The expression of endothelial NOS in femoral, carotid, and renal arteries was determined by Western blot analysis. After 3 weeks of pacing, changes in LV diastolic and systolic parameters were significantly lower in bradykinin-treated than vehicle-treated dogs (LV end-diastolic pressure, +10±3 versus +19±2 mm Hg; time constant of LV isovolumic relaxation, +11±2 versus +17±1 ms; LV wall thickening, -33±18% versus -75±9%; and cardiac output, -16±6% versus -32±6%; all P<0.05). Compared with vehicle-treated dogs, bradykinin-treated dogs had a reduced rightward shift of the diastolic LV pressure-diameter relation and a reduced diastolic LV wall stress. Similar trends were observed after 5 weeks. The vasodilator response to nitroglycerin was preserved in both groups. The response to acetylcholine was blunted in vehicle-treated but preserved in bradykinin-treated dogs. Vascular endothelial NOS expression decreased in vehicle-treated but was preserved in bradykinin-treated dogs.

Conclusions— In conscious dogs, chronic bradykinin infusion delays the heart failure progression by preserving LV diastolic and systolic functions and by preserving vascular endothelial function.

Key Words: bradykinin • heart failure • endothelium

This article has been cited by other articles:

				C Di Mario and H Griffiths Treating multivessel disease in the era of coated stents: conclusion Heart, September 1, 2004; 90(9): 1003 - 1003. [Full Text] [PDF]

				Y. Liao, M. Asakura, S. Takashima, A. Ogai, Y. Asano, Y. Shintani, T. Minamino, H. Asanuma, S. Sanada, J. Kim, et al. Celiprolol, A Vasodilatory {beta}-Blocker, Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Prevents the Transition to Heart Failure via Nitric Oxide-Dependent Mechanisms in Mice Circulation, August 10, 2004; 110(6): 692 - 699. [Abstract] [Full Text] [PDF]